Uniphar plc logo

Uniphar plc (UPR)

Market Closed
10 Aug, 15:28
ISE ISE
4. 28
+0.01
+0.2345%
- Market Cap
- P/E Ratio
0.01% Div Yield
171,187 Volume
- Eps
4.26
Previous Close
Add Transaction
Day Range
4.22 4.46
Year Range
3.38 4.97
Want to track UPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

UPR closed yesterday higher at €4.28, an increase of 0.2345% from Friday's close, completing a monthly decrease of -3.8245% or -€0.17. Over the past 12 months, UPR stock gained 20.0843%.
UPR is not paying dividends to its shareholders.
The last earnings report, released on Feb 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ISE (EUR).

UPR Chart

Uniphar plc (UPR) FAQ

What is the stock price today?

The current price is €4.28.

On which exchange is it traded?

Uniphar plc is listed on ISE.

What is its stock symbol?

The ticker symbol is UPR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.01%.

What is its market cap?

As of today, no market cap data is available.

Has Uniphar plc ever had a stock split?

No, there has never been a stock split.

Uniphar plc Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Gerard Rabbette B.Comm FCA CEO
ISE Exchange
IE00BJ5FQX74 ISIN
Ireland Country
3,500 Employees
20 Apr 2023 Last Dividend
- Last Split
- IPO Date

Overview

Uniphar plc is a diversified healthcare services provider with its headquarters in Ireland, playing a significant role in the pharmaceutical and healthcare sectors. Its primary goal is to streamline operations and improve efficiency within these industries by acting as a crucial link between healthcare manufacturers and the end points of pharmacies, hospitals, and healthcare professionals. Thanks to its extensive supply chain network, Uniphar facilitates the provision of essential healthcare products and services across Europe and internationally. The company prioritizes the delivery of integrated services through its three main divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail, each dedicated to adding value and enhancing different facets of healthcare management.

Products and Services

Uniphar plc offers a wide range of services through its three specialized divisions, designed to meet the intricate needs of the healthcare and pharmaceutical industries:

  • Commercial & Clinical

    This division focuses on assisting pharmaceutical companies in introducing new products to the market. It offers critical support in areas such as contract sales and marketing, playing a fundamental role in the lifecycle of pharmaceutical products by ensuring they reach the market efficiently and effectively.

  • Product Access

    Specializing in the distribution of medications that are either unlicensed or targeted at rare diseases, the Product Access division is pivotal in ensuring patients gain access to the treatments they need. This division addresses the challenges associated with obtaining necessary medications, particularly those that aren't readily available through standard channels.

  • Supply Chain & Retail

    With a focus on optimizing logistics and distribution strategies, this division is essential in improving product availability to end consumers. The Supply Chain & Retail division enhances the efficiency of the delivery process from manufacturers to pharmacies, hospitals, and healthcare professionals, ensuring that essential healthcare products are accessible when and where needed.

Contact Information

Address: 4045 Kingswood Road
Phone: 353 1 428 7777